Skin Lesions
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
OrlucentCA - Los Gatos
1 programPilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
OrlucentPilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.
Clinical Trials (1)
Total enrollment: 126 patients across 1 trials
NCT02009085OrlucentPilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.
Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.
Start: Jun 2013Est. completion: Jun 2017126 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.